-The Economic Times The information commissioner's order asking that stringent disclosure norms prevail on political parties is a welcome move. Transparency with regard to political parties, especially when it concerns funding, is extremely important in a democracy as this is where political corruption begins. In the past, there have been allegations of quid pro quo between big corporate houses, who fund parties in elections, and policy changes effected to suit them. Some...

-The Indian Express Bringing political parties under RTI is a bad, and anti-political, idea In a radical ruling, the chief information commissioner has decided that political parties should be open to scrutiny under the right to information. Six national parties have been asked to appoint officers to handle requests, and proactively share information about their finances and voluntary contributions, including donor information. The logic is that parties get public land and offices,...

-Tehelka.com There are few figures from the adivasi community in India who have made a bigger dent in the collective imagination of the country than Dayamani Barla. The "iron lady of Jharkhand" has been instrumental in articulating adivasi struggles against displacement and deprivation on national and international platforms. Dayamani, who was recently imprisoned in Jharkhand for her involvement in the Nagri people's movement, has won the first Ellen L Lutz Indigenous...

-The Hindu "Farming is fascinating. The only thing is that it requires continuous hard-work and devotion without any distraction" says Mr. Barun Singh, a government bank manager-turned-farmer. Mr. Barun Singh maintains a vermi-composting unit in a portion of his 10 acre land. A dairy unit is attached to the composting unit so that the cattle dung can be easily utilized for the process without much labour involvement. Waste materials like dried leaves, rotten...

-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational Cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...